| 1 |
Ren P, Hu Y, Peng L, Yang L, Suzuki K, Fang Z, Bai M, Zhou L, Feng Y, Zou Y, Xiong Y, Chen S. Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages. bioRxiv 2023:2022. [PMID: 35982661 DOI: 10.1101/2022.08.09.503414] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Mohapatra RK, Verma S, Kandi V, Sarangi AK, Seidel V, Das SN, Behera A, Tuli HS, Sharma AK, Dhama K. The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review. ChemistrySelect 2023;8. [DOI: 10.1002/slct.202201380] [Reference Citation Analysis]
|
| 3 |
Jacobs JL, Haidar G, Mellors JW. COVID-19: Challenges of Viral Variants. Annu Rev Med 2023;74:31-53. [PMID: 35850493 DOI: 10.1146/annurev-med-042921-020956] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 4 |
Suardana IBK, Mahardika BK, Pharmawati M, Sudipa PH, Sari TK, Mahendra NB, Mahardika GN. Whole-Genome Comparison of Representatives of All Variants of SARS-CoV-2, Including Subvariant BA.2 and the GKA Clade. Adv Virol 2023;2023:6476626. [PMID: 36938489 DOI: 10.1155/2023/6476626] [Reference Citation Analysis]
|
| 5 |
Roohani J, Keikha M. Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned? World J Virol 2022; 11(6): 496-501 [DOI: 10.5501/wjv.v11.i6.496] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Diani S, Leonardi E, Cavezzi A, Ferrari S, Iacono O, Limoli A, Bouslenko Z, Natalini D, Conti S, Mantovani M, Tramonte S, Donzelli A, Serravalle E. SARS-CoV-2—The Role of Natural Immunity: A Narrative Review. JCM 2022;11:6272. [DOI: 10.3390/jcm11216272] [Reference Citation Analysis]
|
| 7 |
Park YJ, Pinto D, Walls AC, Liu Z, De Marco A, Benigni F, Zatta F, Silacci-Fregni C, Bassi J, Sprouse KR, Addetia A, Bowen JE, Stewart C, Giurdanella M, Saliba C, Guarino B, Schmid MA, Franko NM, Logue JK, Dang HV, Hauser K, di Iulio J, Rivera W, Schnell G, Rajesh A, Zhou J, Farhat N, Kaiser H, Montiel-Ruiz M, Noack J, Lempp FA, Janer J, Abdelnabi R, Maes P, Ferrari P, Ceschi A, Giannini O, de Melo GD, Kergoat L, Bourhy H, Neyts J, Soriaga L, Purcell LA, Snell G, Whelan SPJ, Lanzavecchia A, Virgin HW, Piccoli L, Chu HY, Pizzuto MS, Corti D, Veesler D. Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science 2022;:eadc9127. [PMID: 36264829 DOI: 10.1126/science.adc9127] [Reference Citation Analysis]
|
| 8 |
Seaman MS, Siedner MJ, Boucau J, Lavine CL, Ghantous F, Liew MY, Mathews JI, Singh A, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Lipiner T, Kittilson A, Melberg M, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Goldberg MB, Luban J, Li JZ, Barczak AK, Lemieux JE. Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant. JCI Insight 2022;7:e159944. [DOI: 10.1172/jci.insight.159944] [Reference Citation Analysis]
|
| 9 |
Lu C, Zhang Y, Liu X, Hou F, Cai R, Yu Z, Liu F, Yang G, Ding J, Xu J, Hua X, Pan X, Liu L, Lin K, Wang Z, Li X, Lu J, Zhang Q, Li Y, Hu C, Fan H, Liu X, Wang H, Jia R, Xu F, Wang X, Huang H, Zhao R, Li J, Cheng H, Jia W, Yang X. Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine.. [DOI: 10.1101/2022.09.06.506714] [Reference Citation Analysis]
|
| 10 |
Lai J, Coleman KK, Sheldon Tai S, German J, Hong F, Albert B, Esparza Y, Srikakulapu AK, Schanz M, Maldonado IS, Oertel M, Fadul N, Gold TL, Weston S, Mullins K, Mcphaul KM, Frieman M, Milton DK. Evolution of SARS-CoV-2 Shedding in Exhaled Breath Aerosols.. [DOI: 10.1101/2022.07.27.22278121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Chotpitayasunondh T, Fisher DA, Hsueh P, Lee P, Nogales Crespo K, Ruxrungtham K. Exploring the Role of Serology Testing to Strengthen Vaccination Initiatives and Policies for COVID-19 in Asia Pacific Countries and Territories: A Discussion Paper. IJTM 2022;2:275-308. [DOI: 10.3390/ijtm2030024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 12 |
Ortega MA, García-montero C, Fraile-martinez O, Colet P, Baizhaxynova A, Mukhtarova K, Alvarez-mon M, Kanatova K, Asúnsolo A, Sarría-santamera A. Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths. JPM 2022;12:995. [DOI: 10.3390/jpm12060995] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 13 |
Miyamoto S, Arashiro T, Ueno A, Kanno T, Saito S, Katano H, Iida S, Ainai A, Ozono S, Hemmi T, Hirata Y, Moriyama S, Kotaki R, Kinoshita H, Yamada S, Shinkai M, Fukushi S, Takahashi Y, Suzuki T. Viral load and timing of infection define neutralization diversity to SARS-CoV-2 infection.. [DOI: 10.1101/2022.06.15.22276432] [Reference Citation Analysis]
|
| 14 |
K A, Sharma A, Kumar D, Singh SK, Gupta G, Chellappan DK, Dua K, Nagraik R. Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review. J Med Virol 2022. [PMID: 35705439 DOI: 10.1002/jmv.27936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Qu P, Faraone JN, Evans JP, Zou X, Zheng Y, Carlin C, Bednash JS, Lozanski G, Mallampalli RK, Saif LJ, Oltz EM, Mohler PJ, Gumina RJ, Liu S. Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.. [DOI: 10.1101/2022.05.16.492158] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 16 |
Lu R, Liang K, Chiang H, Hsu F, Lin H, Chen W, Ke F, Kumari M, Chou Y, Wu H. Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice.. [DOI: 10.1101/2022.04.19.488843] [Reference Citation Analysis]
|
| 17 |
Javanmardi K, Segall-shapiro TH, Chou C, Boutz DR, Olsen RJ, Xie X, Xia H, Shi P, Johnson CD, Annapareddy A, Weaver S, Musser JM, Ellington AD, Finkelstein IJ, Gollihar JD. Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein.. [DOI: 10.1101/2022.04.18.488614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 18 |
Bracis C, Moore M, Swan DA, Matrajt L, Anderson L, Reeves DB, Burns E, Schiffer JT, Dimitrov D. Improving vaccination coverage and offering vaccine to all school-age children allowed uninterrupted in-person schooling in King County, WA: Modeling analysis. Math Biosci Eng 2022;19:5699-716. [PMID: 35603374 DOI: 10.3934/mbe.2022266] [Reference Citation Analysis]
|
| 19 |
Kurhade C, Zou J, Xia H, Cai H, Yang Q, Cutler M, Cooper D, Muik A, Jansen KU, Xie X, Swanson KA, Shi P. Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine.. [DOI: 10.1101/2022.03.24.485633] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 20 |
Bruel T, Hadjadj J, Maes P, Planas D, Seve A, Staropoli I, Guivel-benhassine F, Porrot F, Bolland W, Nguyen Y, Casadevall M, Charre C, Péré H, Veyer D, Prot M, Baidaliuk A, Cuypers L, Planchais C, Mouquet H, Baele G, Mouthon L, Hocqueloux L, Simon-loriere E, André E, Terrier B, Prazuck T, Schwartz O. Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies.. [DOI: 10.1101/2022.03.09.22272066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Peng P, Feng C, Hu J, He C, Deng H, Fan Q, Xiang J, Tang G, Jiang M, Hu F, Li F, Wang K, Tang N, Tang X, Huang A. Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine booster.. [DOI: 10.1101/2022.03.07.483373] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 22 |
Erster O, Kabat A, Asraf H, Levy V, Mannasse B, Azar R, Nemet I, Kliker L, Fleishon S, Mandelboim M, Mendelson E, Zuckerman NS. NOVEL RT-qPCR ASSAYS ENABLE RAPID DETECTION AND DIFFERENTIATION BETWEEN SARS-COV-2 OMICRON (BA.1) AND BA.2 VARIANTS.. [DOI: 10.1101/2022.02.22.22271222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Bartsch YC, Cizmeci D, Kang J, Gao H, Shi W, Chandrashekar A, Collier AY, Chen B, Barouch DH, Alter G. BA.2 evasion of vaccine induced binding and functional non-neutralizing antibodies.. [DOI: 10.1101/2022.02.25.22271511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Sidik SM. Had Omicron? You're unlikely to catch its rising variant. Nature 2022. [PMID: 35217841 DOI: 10.1038/d41586-022-00558-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Callaway E. Why does the Omicron sub-variant spread faster than the original? Nature 2022. [PMID: 35177843 DOI: 10.1038/d41586-022-00471-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 30.0] [Reference Citation Analysis]
|
